J Korean Diabetes > Volume 17(4); 2016 > Article
The Journal of Korean Diabetes 2016;17(4):277-281.
DOI: https://doi.org/10.4093/jkd.2016.17.4.277    Published online December 30, 2016.
임신 중기까지 메트포르민과 보글리보스를 복용한 제2형 당뇨병 1예
김여운, 곽재훈, 여세환, 문성수, 이영실
A Pregnant Woman with Type 2 Diabetes Unintentionally Exposed to Metformin and Voglibose until the Second Trimester of Pregnancy: A Case Report.
Yeo Un Kim, Jae Hoon Kwak, Se Hwan Yeo, Seong Su Moon, Young Sil Lee
Department of Internal Medicine, Dongguk University College of Medicine, Gyeongju, Korea. ysbae28@hanmail.net
Abstract
Use of oral hypoglycemic agents during pregnant women with type 2 diabetes is controversial due to safety issues. Recently, randomized controlled trials support short-term safety of glyburide and metformin for the treatment of gestational diabetes mellitus. However, long-term safety data are not available. Moreover, use of oral hypoglycemic agents, except for metformin and glyburide, during pregnancy were limited to a few case reports. We report the case of a pregnant woman with type 2 diabetes unintentionally exposed to metformin and voglibose in addition to lercanidipine and bisoprolol during fetal organogenesis. The patient was continuously exposed to oral agents because we were not aware of her pregnancy until 22 weeks of gestation. After pregnancy was confirmed, we replaced oral hypoglycemic agents with insulin and discontinue betablockers. Delivery occurred without maternal or fetal complications.
Key Words: Diabetes mellitus type 2, Hypoglycemic agents, Pregnancy
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 327 View
  • 1 Download
Related articles


Editorial Office
101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-714-9064    Fax: +82-2-714-9084    E-mail: diabetes@kams.or.kr                

Copyright © 2021 by Korean Diabetes Association. All rights reserved.

Developed in M2PI

Close layer